HPR156 Payment and Reimbursement Models for Innovative High-Priced Hospital Drugs in the Netherlands: A Survey of Stakeholder's Attitudes and Experiences

Autor: MHE Callenbach, RA Vreman, WG Goettsch, AK Mantel-Teeuwisse

Publikováno v: Value in Health. 25:S261

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::645936d5e45765d64154e648f8e473d1
https://doi.org/10.1016/j.jval.2022.09.1285

Illustrating the Financial Consequences of Outcome-Based Payment Models From a Payers Perspective: The Case of Autologous Gene Therapy Atidarsagene Autotemcel (Libmeldy®).

Autor: Callenbach MHE; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands., Schoenmakers D; Department of Child Neurology, Expertise Center Amsterdam Leukodystrophy Center, including lead of MLDi registry, Emma's Children's Hospital, Amsterdam UMC, Amsterdam, The Netherlands; Medicine for Society, Platform at Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands., Vreman RA; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands; National Health Care Institute (ZIN), Diemen, The Netherlands., Vijgen S; National Health Care Institute (ZIN), Diemen, The Netherlands., Timmers L; National Health Care Institute (ZIN), Diemen, The Netherlands., Hollak CEM; Medicine for Society, Platform at Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands; Department of Endocrinology and Metabolism, Expertise Center for Inborn Errors of Metabolism, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands., Mantel-Teeuwisse AK; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands., Goettsch WG; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands; National Health Care Institute (ZIN), Diemen, The Netherlands. Electronic address: w.g.goettsch@uu.nl.

Publikováno v: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2024 Aug; Vol. 27 (8), pp. 1046-1057. Date of Electronic Publication: 2024 May 23.

Importance of aligning the implementation of new payment models for innovative pharmaceuticals in European countries.

Autor: Kaló Z; Center for Health Technology Assessment, Semmelweis University, Budapest, Hungary.; Syreon Research Institute, Budapest, Hungary., Niewada M; Department of Experimental and Clinical Pharmacology, Medical University of Warsaw, Warsaw, Poland., Bereczky T; Deutsche Aidshilfe e. V., Berlin, Germany., Goettsch W; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands.; National Health Care Institute (ZIN), Diemen, The Netherlands., Vreman RA; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands., Xoxi E; Postgraduate School of Health Economics and Management (ALTEMS), Università Cattolica del Sacro Cuore, Roma, Italy., Trusheim M; Center for Biomedical System Design, Tufts Medical Center, Boston, MA, USA., Callenbach MHE; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands., Nagy L; Syreon Research Institute, Budapest, Hungary., Simoens S; Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.

Publikováno v: Expert review of pharmacoeconomics & outcomes research [Expert Rev Pharmacoecon Outcomes Res] 2024 Feb; Vol. 24 (2), pp. 181-187. Date of Electronic Publication: 2024 Jan 25.

When Reality Does Not Meet Expectations-Experiences and Perceived Attitudes of Dutch Stakeholders Regarding Payment and Reimbursement Models for High-Priced Hospital Drugs.

Autor: Callenbach MHE; Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG Utrecht, The Netherlands., Vreman RA; Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG Utrecht, The Netherlands.; National Health Care Institute (ZIN), 1112 ZA Diemen, The Netherlands., Mantel-Teeuwisse AK; Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG Utrecht, The Netherlands., Goettsch WG; Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG Utrecht, The Netherlands.; National Health Care Institute (ZIN), 1112 ZA Diemen, The Netherlands.

Publikováno v: International journal of environmental research and public health [Int J Environ Res Public Health] 2022 Dec 26; Vol. 20 (1). Date of Electronic Publication: 2022 Dec 26.